CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression

被引:70
作者
Oishi, K.
Ohkura, N.
Wakabayashi, M.
Shirai, H.
Sato, K.
Matsuda, J.
Atsumi, G.
Ishida, N.
机构
[1] Natl Inst Adv Ind Sci & Technol, Clock Cell Biol Res Grp, Tsukuba, Ibaraki 3058566, Japan
[2] Teikyo Univ, Fac Pharmaceut Sci, Dept Clin Mol Biol, Kanagawa, Japan
[3] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan
关键词
adipose tissue; circadian clock; Clock mutant mouse; ob/ob mouse; obesity; plasminogen activator inhibitor-1;
D O I
10.1111/j.1538-7836.2006.02032.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: An increased level of obesity-induced plasma plasminogen activator inhibitor-1 (PAI-1) is considered a risk factor for cardiovascular disease. Aim: The present study investigates whether the circadian clock component CLOCK is involved in obesity-induced PAI-1 elevation. Methods: We examined plasma PAI-1 and mRNA expression levels in tissues from leptin-deficient obese and diabetic ob/ob mice lacking functional CLOCK protein. Results: Our results demonstrated that plasma PAI-1 levels were augmented in a circadian manner in accordance with the mRNA expression levels in ob/ob mice. Surprisingly, a Clock mutation normalized the plasma PAI-1 concentrations in accordance with the mRNA levels in the heart, lung and liver of ob/ob mice, but significantly increased PAI-1 mRNA levels in adipose tissue by inducing adipocyte hypertrophy in ob/ob mice. The Clock mutation also normalized tissue PAI-1 antigen levels in the liver but not in the adipose tissue of ob/ob mice. Conclusion: These observations suggest that CLOCK is involved in obesity-induced disordered fibrinolysis by regulating PAI-1 gene expression in a tissue-dependent manner. Furthermore, it appears that obesity-induced PAI-1 production in adipose tissue is not closely related to systemic PAI-1 increases in vivo.
引用
收藏
页码:1774 / 1780
页数:7
相关论文
共 42 条
[11]  
Heaton JH, 2003, THROMB HAEMOSTASIS, V89, P959
[12]   SREBPs suppress IRS-2-mediated insulin signalling in the liver [J].
Ide, T ;
Shimano, H ;
Yahagi, N ;
Matsuzaka, T ;
Nakakuki, M ;
Yamamoto, T ;
Nakagawa, Y ;
Takahashi, A ;
Suzuki, H ;
Sone, H ;
Toyoshima, H ;
Fukamizu, A ;
Yamada, N .
NATURE CELL BIOLOGY, 2004, 6 (04) :351-357
[13]   PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance [J].
Kubota, N ;
Terauchi, Y ;
Miki, H ;
Tamemoto, H ;
Yamauchi, T ;
Komeda, K ;
Satoh, S ;
Nakano, R ;
Ishii, C ;
Sugiyama, T ;
Eto, K ;
Tsubamoto, Y ;
Okuno, A ;
Murakami, K ;
Sekihara, H ;
Hasegawa, G ;
Naito, M ;
Toyoshima, Y ;
Tanaka, S ;
Shiota, K ;
Kitamura, T ;
Fujita, T ;
Ezaki, O ;
Aizawa, S ;
Nagai, R ;
Tobe, K ;
Kimura, S ;
Kadowaki, T .
MOLECULAR CELL, 1999, 4 (04) :597-609
[14]   On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice [J].
Lijnen, HR ;
Alessi, MC ;
Van Hoef, B ;
Collen, D ;
Juhan-Vague, I .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) :1174-1179
[15]   CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression [J].
Maemura, K ;
de la Monte, SM ;
Chin, MT ;
Layne, MD ;
Hsieh, CM ;
Yet, SF ;
Perrella, MA ;
Lee, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36847-36851
[16]   Circadian variation in stroke onset: Identical temporal pattern in ischemic and hemorrhagic events [J].
Manfredini, R ;
Boari, B ;
Smolensky, MH ;
Salmi, R ;
la Cecilia, O ;
Malagoni, AM ;
Haus, E ;
Manfredini, F .
CHRONOBIOLOGY INTERNATIONAL, 2005, 22 (03) :417-453
[17]   Control mechanism of the circadian clock for timing of cell division in vivo [J].
Matsuo, T ;
Yamaguchi, S ;
Mitsui, S ;
Emi, A ;
Shimoda, F ;
Okamura, H .
SCIENCE, 2003, 302 (5643) :255-259
[18]   Restricted feeding induces daily expression of clock genes and Pai-1 mRNA in the heart of Clock mutant mice [J].
Minami, Y ;
Horikawa, K ;
Akiyama, M ;
Shibata, S .
FEBS LETTERS, 2002, 526 (1-3) :115-118
[19]   Evidence for a potent antiinflammatory effect of rosiglitazone [J].
Mohanty, P ;
Aljada, A ;
Ghanim, H ;
Hofmeyer, D ;
Tripathy, D ;
Syed, T ;
Al-Haddad, W ;
Dhindsa, S ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2728-2735
[20]   Plasminogen activator inhibitor-1 and haemostasis in obesity [J].
Mutch, NJ ;
Wilson, HM ;
Booth, NA .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) :341-347